ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » ALKS Stock Price » ALKS Stock News

Alkermes Share News

 Alkermes (mm) Stock Price
ALKS Stock Price
 Alkermes (mm) Stock Chart
ALKS Stock Chart
 Alkermes (mm) Stock News
ALKS Stock News
 Alkermes (mm) Company Information
ALKS Company Information
 Alkermes (mm) Stock Trades
ALKS Stock Trades

US HOT STOCK FUTURES: HOT STOCKS TO WATCH

Among the companies with shares expected to actively trade in Thursday's session are Lions Gate Entertainment Corp. (LGF), TiVo Inc. (TIVO) and Talbots Inc. (TLB). Lions Gate Entertainment swung to a fiscal fourth-quarter loss as the movie and television studio saw higher marketing and acquisition expenses overshadow soaring revenue from its two blockbuster young-adult series. Shares slid 3.5% to $12.40 premarket amid the surprise loss. TiVo swung to a fiscal first-quarter loss as litigation and marketing expenses rose, though the company reported an increase in subscribers. Shares slid 5.7% to $8.45 premarket as the company also issued a downbeat second-quarter outlook. Talbots agreed to be acquired by Sycamore Partners in a deal valued at about $193.3 million, far less than the struggling retailer stood to receive in a potential deal that fell apart last week. The struggling retailer's shareholders will receive $2.75 a share, down from the former offer of $3.05 a share. Shares more than doubled premarket to $2.58 after tanking in the wake of the failed bid. Leap Wireless International Inc.'s (LEAP) Cricket prepaid phone service will start selling Apple Inc.'s (AAPL) iPhone next month, making it the first prepaid carrier to offer the device in the U.S. Shares jumped 5.8% to $5.77 in premarket trade following the disclosure. Ciena Corp.'s (CIEN) fiscal second-quarter loss narrowed amid fewer acquisition and integration-related charges and as the network gear maker also posted stronger-than-expected revenue growth. Shares were up 6.7% at $12.68 in premarket trading as Ciena reported a surprise adjusted profit. Peer JDS Uniphase Corp. (JDSU) also traded up, gaining 0.7% to $10.07 premarket. Movado Group Inc.'s (MOV) fiscal first-quarter profit surged as the luxury watchmaker had robust sales growth of its accessible luxury and licensed-brand categories. Shares climbed 2.6% to $29.21 premarket. Joy Global Inc.'s (JOY) fiscal second-quarter earnings rose 32% as the mining equipment maker increased shipments in its core underground and surface mining businesses, helped by recent acquisitions. But while its results topped consensus, the company isn't terribly optimistic near-term, listing a litany of concerns ranging from slowing growth in China to the euro-zone woes to a lack of economic catalysts in the U.S. Shares slipped 1.9% to $57.76 premarket. F5 Networks Inc. (FFIV) said its head of worldwide sales, Executive Vice President Mark Anderson, resigned after about eight years with the network-equipment provider company. He was replaced by Dave Feringa, senior vice president for Americas sales. Shares dropped 3.7% premarket to $103.60 amid the departure. National Oilwell Varco Inc. (NOV) agreed to acquire CE Franklin Ltd. (CFK, CFT.T) for about C$231 million, giving the manufacturer of energy-production equipment a supplier of similar products. National Oilwell plans to pay C$12.75 per share for CE Franklin, a 36% premium over its Wednesday closing price on the Toronto Stock Exchange. CE Franklin's U.S.-traded shares jumped 35% to $12.25 premarket. Chelsea Therapeutics International Ltd. (CHTP) said a recent clinical study of its investigational rheumatoid arthritis treatment CH-4051 missed a primary endpoint and the small drug maker had no further plans to develop the medication. Shares fell 18% to $1.60 in premarket trading. BioMarin Pharmaceutical Inc. (BMRN) said it will offer 6.5 million shares and retained broad discretion on the use of the funds. Shares were down 4% at $36.76 premarket. Coldwater Creek Inc.'s (CWTR) fiscal first-quarter loss narrowed as the women's apparel retailer reported lower overhead costs and improved margins, though revenue fell more than expected. Shares rose 6.6% premarket to 90 cents. Watchlist: Biopharmaceutical firm Alkermes PLC (ALKS) said it won't advance its study of its opioid-induced constipation treatment, ALKS 37, after the drug failed to meet the company's goals in a recent trial. AptarGroup Inc. (ATR) has agreed to acquire the Stelmi Group, a maker of elastomer primary-packaging components for injectable drug delivery, for approximately EUR165 million ($207 million) in a deal that expands the dispenser maker's offerings for the pharmaceutical industry. AT&T Inc. (T) reached a tentative agreement for a one-year contract extension for nearly 7,000 core wireline workers, an agreement that comes before the contract expires on June 23. Endologix Inc. (ELGX) said it planned to offer 2.7 million shares, as the company looks to use the proceeds for general-corporate needs, which may include research and development and capital expenditures. MSCI Inc. (MSCI) said Chief Financial Officer David M. Obstler will resign to pursue other interests, and Robert Qutub was appointed to replace him. Noble Energy Inc. (NBL) agreed to sell its stake in certain properties in the U.K.'s North Sea to Maersk Oil North Sea Ltd. for about $127 million, as the oil-and-gas explorer continues to divest its noncore properties. NV Energy Inc. (NVE) on Wednesday said its Chief Financial Officer Dilek Samil would become chief operating officer, and named Caesars Entertainment Corp.'s (CZR) financial chief Jonathan Halkyard as its new CFO. Tengion Inc. (TNGN) said its board approved a 1-for-10 reverse stock split in an effort to raise the clinical-stage regenerative medicine company's per-share trading price above $1 to comply with Nasdaq listing requirements. Zumiez Inc. (ZUMZ) posted a 13.7% jump in May same-store sales while analysts expected a 6.6% rise. The company has been on a tear, delivering strong numbers as teenage consumers respond to its surfing- and snowboarding-related apparel. -Edited By Corrie Driebusch and Nathalie Tadena, Dow Jones Newswires; 212-416-2143; corrie.driebusch@dowjones.com

Stock News for Alkermes (ALKS)
DateTimeHeadline
11/15/201309:01:37HBK Investments LP 3Q 13F: Largest Eliminations
11/15/201309:01:27HBK Investments LP 3Q 13F: Largest Eliminations -2-
11/15/201309:01:27HBK Investments LP 3Q 13F: Largest Sales
11/15/201309:01:27HBK Investments LP 3Q 13F: Largest Purchases
11/15/201308:22:25Janus Capital Management 3Q 13F: Largest Purchases -2-
11/15/201308:22:24Janus Capital Management 3Q 13F: Largest Purchases
11/15/201308:22:24Janus Capital Management 3Q 13F: Holdings As Of -2-
11/15/201308:22:23Janus Capital Management 3Q 13F: Holdings As Of Sep 30
10/10/201309:29:34U.S. Hot Stocks Futures: Hot Stocks to Watch
05/31/201209:19:14US HOT STOCK FUTURES: HOT STOCKS TO WATCH
01/30/201217:42:15US Stocks Edge Lower As Europe's Debt Flashpoints Weigh
01/30/201208:02:33US Stock Futures Lower On Renewed Worries Over Greece
01/27/201216:12:26FDA Approves Amylin's Bydureon Diabetes Drug After Delays
07/28/201109:30:07Amylin, Eli Lilly And Alkermes Submit Reply To FDA On Bydureon
07/27/201105:30:27CORRECT: Elan Confirms Outlook As Quarterly Net Loss Narrows
07/18/201115:19:27Alkermes Sees Sales Growth After Merger With Elan Drug Tech
07/12/201110:09:05Elan To Close Pennsylvania Site Ahead Of Unit Sale To Alkermes
06/24/201119:46:35Amylin, MannKind Shares Rise On Diabetes Data Releases
06/21/201107:02:05Lilly, Amylin, Alkermes Diabetes Drug Gets EU Approval
05/09/201104:46:15Elan Sells EDT Unit To Alkermes To Generate Cash, Cut Debt

Alkermes and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad